Drug intelligence / Profile preview

3'-Oxo-Adenosine

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Overview

3'-Oxo-Adenosine is a synthetic small molecule nucleoside analog belonging to the class of organic compounds known as 6-aminopurines, which are purines carrying an amino group at position 6. It is structurally related to adenosine but features an oxo (keto) group at the 3' position of the ribose moiety. The compound has not been approved for clinical use and is classified as experimental, with no reported indications or clinical trials beyond preclinical research. Its mechanism of action and pharmacological effects have not been characterized in detail in available sources[1].

Other names: 3'-Oxo-Adenosine

Beyond the preview

Go deeper on 3'-Oxo-Adenosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3'-Oxo-Adenosine.

Explore the full profile